HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ordovas, J. M. Articles by Schaefer, E. J. Search for Related Content PubMed PubMed Citation Articles by Ordovas, J. M. Articles by Schaefer, E. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 28, 371-380, Copyright © 1987 by Lipid Research, Inc.

ARTICLES

Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms

JM Ordovas, L Litwack-Klein, PW Wilson, MM Schaefer and EJ Schaefer

Minigel methodology has been utilized for apolipoprotein (apo) E isoform phenotyping and criteria for distinguishing the apoE4/4 phenotype (mean apoE4/apoE3 ratio: 5.81) from the apoE4/3 phenotype (mean ratio: 1.01) and the apoE3/3 phenotype (mean apoE3/apoE2 ratio: 2.67) from the apoE3/2 phenotype (mean ratio: 0.76) based on gel scanning were developed. ApoE allele frequencies in 1209 subjects were: apoE3, 0.786; apoE4, 0.135; apoE2, 0.075; apoE5, 0.002; and apoE1, 0.002. Subjects with the apoE2 allele tended to have higher plasma very low density lipoprotein (VLDL) cholesterol and lower low density lipoprotein (LDL) cholesterol concentrations than subjects with the apoE3 allele, while the converse was true for subjects with the apoE4 allele. Subjects with the rare apoE1 allele had values similar to those with the apoE2 allele, while subjects with the rare apoE5 allele had values similar to those with the apoE4 allele.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Yin, S. Pan, J. Wu, W. Lin, and D. Yang Apolipoprotein E Gene Polymorphism and Serum Lipid Levels in the Guangxi Hei Yi Zhuang and Han Populations Experimental Biology and Medicine, April 1, 2008; 233(4): 409 - 418. [Abstract] [Full Text] [PDF]

				S. Zareparsi, A. C. Reddick, K. E. H. Branham, K. B. Moore, L. Jessup, S. Thoms, M. Smith-Wheelock, B. M. Yashar, and A. Swaroop Association of Apolipoprotein E Alleles with Susceptibility to Age-Related Macular Degeneration in a Large Cohort from a Single Center Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1306 - 1310. [Abstract] [Full Text] [PDF]

				Z. S. Tan, S. Seshadri, A. Beiser, P. W. F. Wilson, D. P. Kiel, M. Tocco, R. B. D'Agostino, and P. A. Wolf Plasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease: The Framingham Study Arch Intern Med, May 12, 2003; 163(9): 1053 - 1057. [Abstract] [Full Text] [PDF]

				J. P. Beilby, C. C.J. Hunt, L. J. Palmer, C. M.L. Chapman, J. P. Burley, B. M. McQuillan, P. L. Thompson, and J. Hung Apolipoprotein E Gene Polymorphisms Are Associated With Carotid Plaque Formation but Not With Intima-Media Wall Thickening: Results From the Perth Carotid Ultrasound Disease Assessment Study (CUDAS) Stroke, April 1, 2003; 34(4): 869 - 874. [Abstract] [Full Text] [PDF]

				R S Wilson, J L Bienias, E Berry-Kravis, D A Evans, and D A Bennett The apolipoprotein E {varepsilon}2 allele and decline in episodic memory J. Neurol. Neurosurg. Psychiatry, December 1, 2002; 73(6): 672 - 677. [Abstract] [Full Text] [PDF]

				S. Seshadri, A. Beiser, J. Selhub, P. F. Jacques, I. H. Rosenberg, R. B. D'Agostino, P. W.F. Wilson, and P. A. Wolf Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease N. Engl. J. Med., February 14, 2002; 346(7): 476 - 483. [Abstract] [Full Text] [PDF]

				E. J Schaefer Lipoproteins, nutrition, and heart disease Am. J. Clinical Nutrition, February 1, 2002; 75(2): 191 - 212. [Abstract] [Full Text] [PDF]

				C. M. Ballantyne, J. A. Herd, E. A. Stein, L. L. Ferlic, J. K. Dunn, A. M. Gotto Jr., and A. J. Marian Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1572 - 1578. [Abstract] [Full Text] [PDF]

				R. S. Bedlack, W. J. Strittmatter, and J. C. Morgenlander Apolipoprotein E and Neuromuscular Disease: A Critical Review of the Literature Arch Neurol, November 1, 2000; 57(11): 1561 - 1565. [Abstract] [Full Text] [PDF]

				A. Salehi, E. J. G. Dubelaar, M. Mulder, and D. F. Swaab Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent PNAS, September 15, 1998; 95(19): 11445 - 11449. [Abstract] [Full Text] [PDF]

				P. W.F. Wilson, E. J. Schaefer, M. G. Larson, and J. M. Ordovas Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis Arterioscler. Thromb. Vasc. Biol., October 1, 1996; 16(10): 1250 - 1255. [Abstract] [Full Text]

				R. Prioli, J. Ordovas, I Rosenberg, E. Schaefer, and M. Pereira Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein Science, December 4, 1987; 238(4832): 1417 - 1419. [Abstract] [PDF]